Skip to main content

Table 1 Comparison of basic data between the case group and the control group

From: Correlation of catecholamine content and clinical influencing factors in depression among psoriasis patients: a case-control study

  The Psoriasis group The Control group zχ2 P
Number, n 90 40   
Age (year) 44(25-53) 44(31-50) -0.374 0.709
Sex (male), n(%) 67(74) 26(65) 1.213 0.271
Course of disease (month) 78(12-120)    
Poor economic condition, n (%) 21(23) 4(10) 2.369 0.124
HAMD score 3(0-9) 2(0-4) -2.115 0.034
PASI score 31(21-39)    
DLQI score 5(2-9)    
AIS score 2(0-9) 0(0-1) -3.407 0.001
Phenylephrine (pg/ml) 30.84(29.16-33.29) 36.77(29.79-41.18) -2.679 0.007
Norepinephrine (pg/ml) 149.28(141.78-161.13) 154.52(142.51-163.88) -1.407 0.159
Dopamine (pg/ml) 53.73.(49.73-56.67) 57.08(52.78-63.11) -2.916 0.004
  1. HAMD Hamilton Depression Scale, PASI Psoriasis Area and Severity Index, DLQI Dermatology Life Quality Index, AIS Athens Insomnia Scale